177Lu-PSMA-1

N/A

Report date: 2025/09/12 17:58:39

NME

Base Information

Drug Name177Lu-PSMA-1

Drug Alias Nameradionuclide therapy (Centre Leon Berard)

ClassificationRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsPositron-emission tomography enhancers

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic NeoplasmsPeritoneal NeoplasmsCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesCentre Léon Bérard

China Registration ClassN/A

Develop Information

Active CompaniesCentre Léon Bérard

Inactive CompaniesN/A

Active IndicationsProstatic NeoplasmsPeritoneal NeoplasmsCarcinoma, Renal Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A